Loading clinical trials...
Loading clinical trials...
Characterizing Diurnal Glucose Patterns of Individuals With Type 1 Diabetes and Eating Disorders
The purpose of this study is to use data from the Continuous Glucose Monitor (CGM) to determine the degree of variation in glucose levels of individuals with an eating disorder and type 1 diabetes and only an eating disorder.
The specific aims of the proposed research are to: 2.1 Determine the degree of variation in glycemic profiles of individuals with an Eating Disorder and Type 1 Diabetes (ED-DMT1) and an Eating Disorder only (ED/only); and 2.2 Determine the impact of nutritional intake and planned physical activity on glucose profiles of individuals with ED-DMT1 and ED/only. These aims will be examined by characterizing: * glucose exposure, as measured by area under the Ambulatory Glucose Profile (AGP) median curve; * glucose variability, as measured by the AGP inter-quartile range; and * glucose stability, as measured by change in the AGP median curve.
Age
14 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Melrose Institute
Minneapolis, Minnesota, United States
Start Date
July 1, 2011
Primary Completion Date
July 1, 2011
Completion Date
May 1, 2013
Last Updated
November 26, 2015
1
ACTUAL participants
Lead Sponsor
HealthPartners Institute
Collaborators
NCT06306586
NCT07179068
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05304104